Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Cidara Therapeutics, Inc. (CDTX)

« Back to company index

CDTX Chatter Timeline

Stock Ticker for CDTX

Most Active Tweeters for CDTX

UserTweets
@BioDonor 26
@thejadedtrader 23
@mmahotstuff1 8
@CaesarBiotech 8
@bulletin_en 8

Recent Tweets for CDTX

titan_v16 @titan_v16
RT @thejadedtrader: $CDTX https://t.co/vd760WI6qo
April 19th 2019, 4:04pm
thejadedtrader @thejadedtrader
$CDTX https://t.co/vd760WI6qo
April 19th 2019, 4:04pm
titan_v16 @titan_v16
RT @thejadedtrader: Great argument for $CDTX cloudbreak antiviral platform which (in mice) provides protection for months. https://t.co/aZf…
April 19th 2019, 1:04pm
thejadedtrader @thejadedtrader
Great argument for $CDTX cloudbreak antiviral platform which (in mice) provides protection for months. https://t.co/aZfenmgva2
April 19th 2019, 11:04am
st_kinne @st_kinne
RT @BioDonor: $CDTX Tute's https://t.co/HnYFrZVx1b
April 19th 2019, 8:04am
BioDonor @BioDonor
$CDTX Tute's https://t.co/HnYFrZVx1b
April 19th 2019, 8:04am
TickerReport @TickerReport
Cidara Therapeutics’ $CDTX Buy Rating Reiterated at Cantor Fitzgerald https://t.co/dKeIph0lNx
April 19th 2019, 1:04am
battagliame30 @battagliame30
@CidaraThera @Contagion_Live Nice! $CDTX
April 18th 2019, 5:04pm
battagliame30 @battagliame30
RT @CidaraThera: CB-012 is the first clinical development candidate from Cidara's Cloudbreak® influenza (antiviral) program. $CDTX SVP of r…
April 18th 2019, 3:04pm
mmahotstuff1 @mmahotstuff1
Were Analysts Bearish Cidara Therapeutics, Inc. $CDTX This Week? https://t.co/jk0hjhNa0C
April 18th 2019, 11:04am
mmahotstuff1 @mmahotstuff1
Cidara Therapeutics, Inc. $CDTX Analysts See $-0.56 EPS https://t.co/ieOZ6smkzB
April 18th 2019, 6:04am
whatsonthorold2 @whatsonthorold2
EPS for Cidara Therapeutics, Inc. $CDTX Expected At $-0.56 https://t.co/8ZQPsVq5gT
April 18th 2019, 6:04am
bibeypost_stock @bibeypost_stock
$-0.56 EPS Expected for Cidara Therapeutics, Inc. $CDTX https://t.co/Qa74DBp40x
April 18th 2019, 6:04am
reurope_stock @reurope_stock
Cidara Therapeutics, Inc. $CDTX EPS Estimated At $-0.56 https://t.co/mTR0jTVJai
April 18th 2019, 6:04am
bbnsnews @bbnsnews
Cidara Therapeutics’ $CDTX “Buy” Rating Reiterated at Cantor Fitzgerald https://t.co/FAzYSkYgF0
April 18th 2019, 5:04am
thefinreviewer @thefinreviewer
Achillion Pharmaceuticals Inc. $CDTX https://t.co/UenIc3T0r5
April 17th 2019, 11:04pm
thefinreviewer @thefinreviewer
Veracyte Inc. $CDTX Comparing side by side https://t.co/0kjZeUnvbp
April 17th 2019, 5:04pm
thefinreviewer @thefinreviewer
Reviewing Regulus Therapeutics Inc. $CDTX's results https://t.co/pQcFTn4r35
April 17th 2019, 5:04pm
BioDonor @BioDonor
RT @thejadedtrader: $cdtx https://t.co/ITH5xsZftf
April 17th 2019, 10:04am
thejadedtrader @thejadedtrader
$cdtx https://t.co/ITH5xsZftf
April 17th 2019, 10:04am
dailypoliticaln @dailypoliticaln
Cantor Fitzgerald Reiterates Buy Rating for Cidara Therapeutics $CDTX https://t.co/10UrTafPp6
April 17th 2019, 3:04am
ZolmaxNews @ZolmaxNews
Cidara Therapeutics’ $CDTX Buy Rating Reiterated at Cantor Fitzgerald https://t.co/aNWXoVvg8K
April 17th 2019, 3:04am
mmahotstuff1 @mmahotstuff1
Analysts See $-0.56 EPS for Cidara Therapeutics, Inc. $CDTX https://t.co/Ke6yRczdfO
April 17th 2019, 1:04am
whatsonthorold2 @whatsonthorold2
EPS for Cidara Therapeutics, Inc. $CDTX Expected At $-0.56 https://t.co/R8VSW6PyxW
April 17th 2019, 1:04am
bibeypost_stock @bibeypost_stock
Cidara Therapeutics, Inc. $CDTX EPS Estimated At $-0.56 https://t.co/NLFeHvm2EP
April 17th 2019, 1:04am
reurope_stock @reurope_stock
Cidara Therapeutics, Inc. $CDTX EPS Estimated At $-0.56 https://t.co/vRuQiuLuhB
April 17th 2019, 1:04am
StockNewsNow @StockNewsNow
$CDTX Cidara Therapeutics Highlights New Data from Multiple Rezafungin Studies Presented at ECCMID 2019 https://t.co/6e0RzH7Vei
April 16th 2019, 1:04pm
thejadedtrader @thejadedtrader
RT @BioDonor: $CDTX Superior in vitro activity, Full protection/treatment of H1N1/H3N2/Tamiflu-resistant H1N1 with a single dose, with effi…
April 16th 2019, 9:04am
thejadedtrader @thejadedtrader
RT @BioDonor: $CDTX ECCMID summarized https://t.co/lZFXAIZP8b
April 16th 2019, 9:04am
BioDonor @BioDonor
$CDTX ECCMID summarized https://t.co/lZFXAIZP8b
April 16th 2019, 8:04am
newswithvalue @newswithvalue
$CDTX: Cidara Therapeutics Highlights New Data from Multiple Rezafungin …: https://t.co/ludeFw6hg1
April 16th 2019, 8:04am
TheMarketsDaily @TheMarketsDaily
Cidara Therapeutics $CDTX Given Buy Rating at Cantor Fitzgerald https://t.co/oWyW6FZz4M
April 16th 2019, 7:04am
macondailynews @macondailynews
Cidara Therapeutics $CDTX Given Buy Rating at Cantor Fitzgerald https://t.co/3fhu4P22mf
April 16th 2019, 7:04am
BioDonor @BioDonor
$CDTX Superior in vitro activity, Full protection/treatment of H1N1/H3N2/Tamiflu-resistant H1N1 with a single dose,… https://t.co/d7bBlr4bkF
April 16th 2019, 7:04am
mmahotstuff1 @mmahotstuff1
EPS for Cidara Therapeutics, Inc. $CDTX Expected At $-0.56 https://t.co/nCbKbKooNr
April 16th 2019, 12:04am
whatsonthorold2 @whatsonthorold2
EPS for Cidara Therapeutics, Inc. $CDTX Expected At $-0.56 https://t.co/P7myKZLtLM
April 16th 2019, 12:04am
reurope_stock @reurope_stock
Cidara Therapeutics, Inc. $CDTX EPS Estimated At $-0.56 https://t.co/Q0bwBA3pam
April 16th 2019, 12:04am
BlogYomi @BlogYomi
Harpoon Therapeutics Inc. $CDTX Comparison side by side https://t.co/awTV4SDHOv
April 15th 2019, 11:04pm
AWG_News @AWG_News
RT @CidaraThera: Cidara CEO @jefflstein comments on results from nonclinical studies, which evaluated the potential of $CDTX's newly select…
April 15th 2019, 3:04pm
thejadedtrader @thejadedtrader
RT @CidaraThera: Key findings from nonclinical studies suggest $CDTX's CB-012 offers superior in vitro activity compared to standard-of-car…
April 15th 2019, 3:04pm
CidaraThera @CidaraThera
Key findings from nonclinical studies suggest $CDTX's CB-012 offers superior in vitro activity compared to standard… https://t.co/BktR10HFt0
April 15th 2019, 3:04pm
AmericanBanking @AmericanBanking
Cidara Therapeutics $CDTX Stock Rating Reaffirmed by Cantor Fitzgerald https://t.co/wDXijC8yls #stocks
April 15th 2019, 1:04pm
StockNewsNow @StockNewsNow
$CDTX Cidara Therapeutics Selects First Clinical Development Candidate from its Cloudbreak Influenza (Antiviral) Pr… https://t.co/bOl0GbwcBx
April 15th 2019, 1:04pm
ConsumerFeed @ConsumerFeed
Cidara Therapeutics’ $CDTX Buy Rating Reaffirmed at Cantor Fitzgerald https://t.co/s0a0zPwEax
April 15th 2019, 1:04pm
CaesarBiotech @CaesarBiotech
RT @CidaraThera: Data supporting the selection of CB-012 as the first clinical development candidate from $CDTX'S Cloudbreak #Influenza (An…
April 15th 2019, 11:04am
romanyuk_e @romanyuk_e
$CDTX news seems very positive. Can't find any reasons for the sell off. Should he up 10%, not the other way around.
April 15th 2019, 10:04am
thejadedtrader @thejadedtrader
RT @CidaraThera: $CDTX’s vision is that a single dose of an AVC could prevent #influenza for an entire flu season, with or without concurre…
April 15th 2019, 9:04am
thejadedtrader @thejadedtrader
RT @CidaraThera: $CDTX’s Cloudbreak AVCs attack #influenza through a dual mechanism: The #antiviral agent neutralizes the influenza virus d…
April 15th 2019, 9:04am
blackswantrader @blackswantrader
RT @CaesarBiotech: The accelerating rise of bispecific antibodies outside of oncology $CDTX bi-specific ADC for anti-infective programs #ga…
April 15th 2019, 9:04am
CaesarBiotech @CaesarBiotech
The accelerating rise of bispecific antibodies outside of oncology $CDTX bi-specific ADC for anti-infective program… https://t.co/h8bKg9ekNE
April 15th 2019, 9:04am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.